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aBstraCt
Submacular haemorrhages, which are mostly caused by exudative age-related macular degeneration, lead to a si-
gnificant deterioration of visual acuity and have a poor prognosis. Therefore, quick implementation of treatment is 
essential.
The aim was to report a case of 68-year-old patient suffering from extensive haemorrhage covering the macula tre-
ated with pure sulphur hexafluoride (SF6) gas infusion and two anti-vascular endothelial growth factor (anti-VEGF) 
intravitreal injections. A patient was referred to the clinic due to a sudden deterioration of vision and the appearance 
of a black spot in central vision in the right eye. The patient underwent the infusion of 0.5 ml of pure SF6 followed 
by maintenance of face-down position postoperatively resulting in partial displacement of submacular haemorrha-
ge. One month after the surgery the patient was referred to two intravitreal injections of anti-VEGF in monthly 
intervals. The effectiveness of the treatment is confirmed by OCT examination and visual acuity results (from CF 1’ 
before treatment to 5/12 after the treatment).
A combination of SF6 gas infusion and anti-VEGF intravitreal injections turned out to be an effective and safe me-
thod of submacular haemorrhage treatment. Early diagnosis and treatment implementation resulted in significant 
improvement of visual acuity.
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introduCtion
Exudative age-related macular degeneration 
(AMD) is the most common cause of submacular 
haemorrhage, which leads to a significant deterio-
ration of visual acuity and has a poor prognosis [1].
Loss of vision is secondary to the toxic, degener-
ative activity of residual blood, which damages pho-
toreceptors [1]; therefore, quick implementation of 
treatment after diagnosis is essential. Hattenbach et al. 
showed that the length of bleeding duration is a pre-
dictor for improved vision [2]. Patients with submac-
ular haemorrhage lasting up to 14 days had two-fold 
increased chances for improved vision than patients 
with bleeding, which lasted from 14 to 21 days. In 
contrast, none of the patients whose bleeding lasted 
for more than 21 days obtained vision improvement.
One of the methods of submacular haemorrhage 
treatment is an intravitreal injection of the tissue 
plasminogen activator (rtPA) through the pars plana 
vitrectomy (PPV). This procedure allows accelera-
OphthalmOlOgy JOurnal 2016, Vol. 1, No. 3
100 www.journals.viamedica.pl/ophthalmology_journal
tion of the lysis of blood, followed by an intravitreal 
injection of gas, which moves the blood from the 
submacular area. An alternative is the administra-
tion of sulphur hexafluoride (SF6) gas without prior 
administration of the tissue plasminogen activa-
tor (rtPA) [3, 4]. As submacular haemorrhage is 
the result of abnormal vasculature from exudative 
AMD, visual stability over time is dependent on the 
control of the underlying disease [5, 6]. Through 
exposure of the macular area in the way of SF6 gas 
administration, better conditions for the subsequent 
application of anti-vascular endothelial growth fac-
tor (anti-VEGF) are obtained to treat the choroidal 
neovascular membranes (CNVM) located there.
Case desCription
A 68-year-old patient came to the ophthalmo-
logic emergency room due to a sudden deterioration 
of visual acuity and the appearance of a black spot 
in central vision in the right eye on the same day. 
The patient’s treatment was conducted in accordance 
with the Declaration of Helsinki. Visual acuity: right 
eye = CF 1’, left eye = 5 / 5.5 s.c. Intraocular pressure 
(IOP): right eye = 14 mmHg, left eye = 15 mmHg. 
In the study with a slit lamp: the right eye and the 
left eye - anterior segments correct, cataracts in both 
eyes. Fundus examination with a slit lamp showed 
an extensive haemorrhage covering the macula in 
the right eye. In the left eye the macula was with-
out reflexes, otherwise there were no pathological 
changes. In an indocyanine green chorioangiography 
(ICG) study in the right eye at the posterior pole 
a vast area of the fluorescence blocking was seen 
in the projection of subretinal haemorrhage, in the 
centre changes from the early phases, a hyperfluo-
rescence focus growing in time and persisting into 
late phases, in favour of the diagnosis of the active 
choroidal neovascularisation (CNV) (Fig. 1).
The patient was admitted to the department 
of ophthalmology for a surgery two days after the 
diagnosis — infusion of 0.5 ml of the pure SF6 gas 
into the vitreous body of the right eye. Visual acuity 
on admission was: right eye = CF 1’ (correction 
does not help). The surgery and postoperative pe-
riod went without complications. The patient was 
discharged home on the second day with visual acu-
ity: right eye = 0.5/50. Antibiotic drops and tropi-
camide topically to the operated eye, and capillary 
stabilising agents in tablets were recommended. The 
patient maintained a face-down position postopera-
tively for a week.
a
B
Figure 1. A photo of the fundus showing an extensive subret-
inal haemorrhage covering the macula (a). In the optical coher-
ence tomography (OCT) image (Optovue Avanti) a distorted layer 
structure of the retina is visible, a hyperreflective structure with 
an accompanying hyporeflective fluid space is present under the 
neurosensory retina and an extensive pigment epithelial detach-
ment (PED) caused by subretinal haemorrhage. Central retinal 
thickness (CRT) = 417 μm (B)
A week after the the SF6 gas infusion the patient 
came to a follow-up appointment to the AMD clin-
ic. Visual acuity: right eye = 5/50 (Fig. 2).
A month after the surgery the patient returned 
for another check-up at the AMD clinic. Visual 
acuity: right eye = 0.5/50 ccor 1.75 – 0.75 sph cyl 
ax 72 = 5/25. In the examination of the fundus 
a significant improvement was seen in relation to 
the preceding examination, the haemorrhage was 
located more paracentrally. CNV was seen in the 
macula (Fig. 3).
Four weeks after the administration of 
SF6 gas the patient received an injection of intra-
vitreal anti-VEGF (bevacizumab) to the operat-
ed eye. A week after the injection she came for 
a check-up to the AMD clinic. Visual acuity: right 
eye = 5/25 ccor + 1.75 sph –0.75 cyl ax 72 (Fig. 4).
Anna Heinke Knudsen et al., SF6 gas and anti-VEGF in the treatment of subretinal haemorrhage in AMD
101www.journals.viamedica.pl/ophthalmology_journal
a
B
Figure 2. A photograph of the fundus one week after the surgery. 
A bubble of SF6 gas visible. As compared to the previous examina-
tion a smaller range of haemorrhage with its slight displacement 
can be seen (a). OCT of the right eye macula after the infusion of 
0.5 ml of the SF6 gas into the vitreous body. CRT = 369 μm (B)
In an OCT examination a week after the in-
travitreal injection of anti-VEGF a dramatic im-
provement of the retinal morphology image was 
achieved, compared to the pre-treatment con-
dition. The outline of the fovea was recovered, 
CRT dropped to 322 μm. There was no fluid 
under the neurosensory retina. Clinically, this 
correlated with the improvement of visual acuity 
of the patient: right eye = 5/25 ccor + 1.75 sph 
–0.75 cyl ax 72.
A month after the first injection the patient re-
ceived a second dose of the injection of intravitre-
al anti-VEGF (bevacizumab) to the right eye. Two 
weeks after the second injection she came for another 
check-up to the AMD clinic. Visual acuity was: right 
eye =5/16 ccor + 1.75 sph –0.75 cyl ax 72, the left 
eye 5/5 f. The patient subjectively reported a signifi-
cant vision improvement. In the fundus examination 
almost complete haemorrhage resorption was visible. 
Only a small haemorrhage remains paracentrally with 
a
B
Figure 3. A photograph of the fundus a month after the adminis-
tration of SF6 gas (a). OCT of the macula one month after the sur-
gery. CRT = 357 μm. The PED remains, no outline of the fovea (B)
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Figure 4. A photograph of the fundus – a significant partial re-
sorption of the haemorrhage is visible (a). The OCT of the macula 
a week after the first injection, the outline of the fovea was visible, 
and there was no fluid under the neurosensory retina. A hyperre-
flective temporal structure was visible from the fovea — CNV (B)
a scar forming. In the OCT an outline of the fovea 
was visible, lack of fluid, and a further reduction of 
the CRT to the value 303 μm was seen (Fig. 5).
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summary
A 68-year-old patient with submacular haem-
orrhage in the right eye in the course of exudative 
AMD underwent a surgical treatment, i.e. the infu-
sion of 0.5 ml of SF6, achieving partial displacement 
of submacular haemorrhage from above the macular 
area down. Then, four weeks after the surgery two 
intravitreal injections of anti-VEGF (bevacizumab) 
were given in a monthly interval. Three months after 
the submacular haemorrhage, the applied treatment 
resulted in a significant improvement in visual acuity 
of the right eye: from CF 1’ to 5/12 ccor +1.75 sph 
–0.75 cyl ax 72. The fundus examination showed 
a significant resorption of the haemorrhage with its 
displacement. The OCT examination revealed the res-
toration of the fovea outline, a relative normalisation 
of retinal morphology, and the absence of fluid under 
the neurosensory retina. The CRT dropped from the 
initial value of 417 μm to 215 μm (in the fovea).
CONCLUSIONS
A combined therapy of pure SF6 gas infusion and 
intravitreal injection of anti-VEGF used in patients 
with early diagnosed submacular haemorrhage in 
the course of the exudative form of AMD can bring 
satisfactory results with a significant improvement 
in visual acuity.
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Figure 5. A photograph of the right eye fundus two weeks 
after the second anti-VEGF injection (a). The OCT of the right eye 
macula (Zeiss) two weeks after the second dose of the injection 
of intravitreal anti-VEGF. CRT= 303 μm. An outline of the fovea 
was visible, elevation of the retina layers temporally from the 
foveola with the CNV hyperreflective structure. No fluid under the 
neurosensory retina (B)
